Melting point	160-161 ºC**
Density	1.164±0.06 g/cm3 (20 º

没有数据	没有数据

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

More

Name	CAS

More

Articles

Peer-Reviewed Papers

The formation and metabolism of N-hydroxymethyl compounds--III. The metabolic conversion of N-methyl and N,N,-dimethylbenzamides to N-hydroxymethyl compounds.D Ross et al.Biochemical pharmacology, 32(11), 1773-1781 (1983-06-01) Design and synthesis of substituted N-methylbenzamide analogues derived from SR 48,968 as neurokinin-2 receptor antagonists.Shih-Chung Huang et al.Bioorganic & medicinal chemistry letters, 14(18), 4779-4782 (2004-08-25) N-Methylanilide and N-methylbenzamide derivatives as phosphodiesterase 10A (PDE10A) inhibitors.John Paul Kilburn et al.Bioorganic & medicinal chemistry, 21(19), 6053-6062 (2013-08-28) Molecular electrostatic potential of orthopramides: implications for their interaction with the D-2 dopamine receptor.H van de Waterbeemd et al.Journal of medicinal chemistry, 29(5), 600-606 (1986-05-01) Thermodynamic analysis of the binding of aromatic hydroxamic acid analogues to ferric horseradish peroxidase.S M Aitken et al.Biochemistry, 40(46), 13980-13989 (2001-11-14) The microsomal demethylation of N,N-dimethylbenzamides. Substituent and kinetic deuterium isotope effects.L Constantino et al.Biochemical pharmacology, 44(4), 651-658 (1992-08-18) Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist.Atsushi Satoh et al.Bioorganic & medicinal chemistry letters, 19(18), 5464-5468 (2009-08-14)

Remarks